BEI update 2: 2014 GPS transparency rankings submitted to journal, data-sharing standards, new team members

These last two weeks Bioethics International (BEI) has been busy advancing ethics, transparency and patient-centricity in the pharmaceutical sector, by:

  1. Submitting our 2014 Good Pharma Scorecard (GPS) rankings for review and publication in a medical journal.  The 2014 rankings will uniquely include a new company ranking to accompany the drug rankings on clinical trial transparency.  We significantly expanded and refined our methodology since the 2012 Harvard Pilot (published in November of 2015  in BMJ Open), especially the FDAAA metrics.
  2. Speaking with drug companies about the forthcoming 2015 GPS rankings, to validate data.
  3. Revising our new trial data-sharing standards, based on industry feedback (non-industry feedback has already been incorporated).
  4. Welcoming a new team member, Evan Greenfield. Evan is a graduate of Harvard Business School and comes to us from Deutsche Bank.  Evan has extensive experience in ESG (Environmental, Social & Governance) and social impact investing.
  5. Kicking off our summer internship program. We are hosting 4 student interns: (1) Nikha In-Amkha, (2) Skylar Iosepovici, (3) Zoe Davidson, and (4) Acacia Sheppard. Nikha is a junior majoring in philosophy with a concentration in entrepreneurship and computer science at Washington & Jefferson College.  More on the other interns in subsequent posts.

Lots more is underway… stay tuned for another update in 2 weeks.

Best, Jennifer E. Miller, PhD, Founder BEI